Want to see IN:DMCC full AI Analyst Report?
Top Page
DMCC Speciality Chemicals Limited
(DMCC)
Select Model
Select Model
Rating:59Neutral
Price Target:
₹273.00
▼(-9.20% Downside)
Action:Reiterated
Date:08/29/26
The score is held back primarily by weak cash flow quality, with FY2026 operating cash flow and free cash flow turning negative despite a revenue and earnings rebound and a generally manageable leverage profile. Technicals add support given the clear uptrend (price above major moving averages) and positive momentum readings. Valuation is neutral-to-moderate (P/E ~18.8) with only a modest dividend yield (~0.8%).
Positive Factors
Revenue rebound
The FY2026 revenue rebound indicates renewed demand and demonstrates that the business can recover after a weaker period. Although the growth path has been uneven, recovering sales provides a stronger base for utilization, operating leverage, and sustained commercial momentum over the next several quarters.
Negative Factors
Weak cash conversion
The reversal to negative operating and free cash flow is the most significant fundamental weakness because reported earnings are no longer translating reliably into liquidity. Persistent inconsistency can increase funding needs, constrain reinvestment, and make the company more vulnerable if working-capital demands or investment intensity remain elevated.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue rebound
The FY2026 revenue rebound indicates renewed demand and demonstrates that the business can recover after a weaker period. Although the growth path has been uneven, recovering sales provides a stronger base for utilization, operating leverage, and sustained commercial momentum over the next several quarters.
Read all positive factors
DMCC Speciality Chemicals Limited (DMCC) vs. iShares MSCI India ETF (INDA)
Market Cap
₹7.85B
Dividend Yield0.79%
Average Volume (3M)4.67K
Price to Earnings (P/E)19.4
Beta (1Y)0.93
Revenue Growth49.58%
EPS Growth43.22%
CountryIN
Employees450
SectorGeneral
Sector StrengthN/A
IndustryChemicals
Share Statistics
EPS (TTM)16.03
Shares Outstanding24,939,932
10 Day Avg. Volume5,704
30 Day Avg. Volume4,665
Financial Highlights & Ratios
PEG Ratio0.67
Price to Book (P/B)1.98
Price to Sales (P/S)0.85
P/FCF Ratio-14.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
DMCC Speciality Chemicals Limited Business Overview & Revenue Model
Company Description
DMCC Speciality Chemicals Limited, alongside its affiliated entities, operates as a manufacturer and global supplier of both specialty and commodity chemicals. Its distribution network spans both domestic Indian markets and international territori...
How the Company Makes Money
null...
DMCC Speciality Chemicals Limited Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
68
Positive
Cash Flow
34
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.08B | 5.82B | 4.31B | 3.26B | 3.85B | 3.25B |
| Gross Profit | 1.11B | 935.49M | 1.33B | 1.14B | 1.37B | 1.28B |
| EBITDA | 812.03M | 643.27M | 570.16M | 366.94M | 387.81M | 467.11M |
| Net Income | 399.78M | 273.29M | 215.28M | 115.89M | 69.31M | 213.40M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 4.46B | 3.80B | 3.77B | 4.01B | 3.84B |
| Cash, Cash Equivalents and Short-Term Investments | 44.55M | 44.55M | 51.52M | 70.63M | 33.50M | 29.59M |
| Total Debt | 0.00 | 865.32M | 470.70M | 877.11M | 1.01B | 933.99M |
| Total Liabilities | -2.48B | 1.97B | 1.53B | 1.68B | 2.03B | 1.90B |
| Stockholders Equity | 2.48B | 2.48B | 2.28B | 2.10B | 1.98B | 1.94B |
Cash Flow | ||||||
| Free Cash Flow | 170.43M | -330.45M | 310.28M | 194.33M | 79.75M | -480.71M |
| Operating Cash Flow | 174.18M | -270.57M | 380.41M | 383.74M | 298.81M | 506.56M |
| Investing Cash Flow | -12.05M | -69.76M | -66.82M | -100.42M | -205.59M | -984.14M |
| Financing Cash Flow | -199.02M | 318.06M | -297.83M | -271.01M | -99.94M | 461.07M |
DMCC Speciality Chemicals Limited Technical Analysis
Positive
300.65
Price Trends
284.55
Positive
274.56
Positive
257.06
Positive
Market Momentum
5.23
Negative
65.30
Neutral
87.81
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:DMCC, the sentiment is Positive. The current price of 300.65 is above the 20-day moving average (MA) of 288.93, above the 50-day MA of 284.55, and above the 200-day MA of 257.06, indicating a bullish trend. The MACD of 5.23 indicates Negative momentum. The RSI at 65.30 is Neutral, neither overbought nor oversold. The STOCH value of 87.81 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:DMCC.
DMCC Speciality Chemicals Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ₹6.59B | 40.77 | ― | ― | -2.70% | -15.41% | |
61 Neutral | ₹10.60B | 12.80 | ― | 0.35% | 13.23% | 22.22% | |
59 Neutral | ₹7.85B | 19.44 | ― | 0.79% | 49.58% | 43.22% | |
58 Neutral | ₹11.32B | 23.59 | ― | 0.99% | 1.41% | 946.41% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
54 Neutral | ₹207.83B | 26.64 | ― | 0.49% | 8.20% | 29.06% | |
49 Neutral | ₹6.16B | 30.50 | ― | 3.93% | -77.13% | ― |
* General Sector Average
IN:DMCC
DMCC Speciality Chemicals Limited
312.40
2.13
0.69%
IN:DEEPAKNTR
Deepak Nitrite Limited
1,531.05
-302.38
-16.49%
IN:INDOAMIN
Indo Amines Limited
141.50
3.16
2.28%
IN:PRIMO
Primo Chemicals Limited
26.60
2.99
12.66%
IN:UNIENTER
Uniphos Enterprises Limited
88.56
-55.65
-38.59%
IN:VALIANTORG
Valiant Organics Limited
456.30
122.10
36.54%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.